<--- Back to Details
First PageDocument Content
Medicine / Clinical medicine / Immunology / Immunosuppressants / RTT / Rheumatology / Orphan drugs / Specialty drugs / Tocilizumab / Autoimmunity / Rituximab / Rheumatoid arthritis
Date: 2016-03-04 10:05:54
Medicine
Clinical medicine
Immunology
Immunosuppressants
RTT
Rheumatology
Orphan drugs
Specialty drugs
Tocilizumab
Autoimmunity
Rituximab
Rheumatoid arthritis

NOVEMBER 2015 TABLE OF CONTENTS INTRODUCTION

Add to Reading List

Source URL: www.abirisk.eu

Download Document from Source Website

File Size: 735,20 KB

Share Document on Facebook

Similar Documents

TOCILIZUMAB FOR THE TREATMENT OF RHEUMATOID ARTHRITIS REPORT BY THE DECISION SUPPORT UNIT  Stephen Palmer, Mark Sculpher

TOCILIZUMAB FOR THE TREATMENT OF RHEUMATOID ARTHRITIS REPORT BY THE DECISION SUPPORT UNIT Stephen Palmer, Mark Sculpher

DocID: 1s1AX - View Document

NOVEMBER 2015 TABLE OF CONTENTS  INTRODUCTION

NOVEMBER 2015 TABLE OF CONTENTS INTRODUCTION

DocID: 1qUAB - View Document

TOCILIZUMAB FOR THE TREATMENT OF RHEUMATOID ARTHRITIS

TOCILIZUMAB FOR THE TREATMENT OF RHEUMATOID ARTHRITIS

DocID: 1pnYX - View Document

JULY 2016 TABLE OF CONTENTS  INTRODUCTION

JULY 2016 TABLE OF CONTENTS INTRODUCTION

DocID: 1pejO - View Document

TABLE OF CONTENTS  INTRODUCTION 2

TABLE OF CONTENTS INTRODUCTION 2

DocID: 1oMip - View Document